Cargando…

Prime, shock and kill: BCL-2 inhibition for HIV cure

While modern HIV therapy can effectively suppress viral replication, the persistence of the latent reservoir posits the greatest hurdle to complete cure. The “shock and kill” strategy is under investigation for HIV therapy, aiming to reactivate latent HIV, and subsequently eliminate it through anti-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chandrasekar, Aswath P., Badley, Andrew D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9631312/ https://www.ncbi.nlm.nih.gov/pubmed/36341439 http://dx.doi.org/10.3389/fimmu.2022.1033609

Ejemplares similares

Making sense of how HIV kills infected CD4 T cells: implications for HIV cure
por: Cummins, Nathan W, et al.
Publicado: (2014)

The BCL-2 Inhibitor Venetoclax Augments Immune Effector Function Mediated by Fas Ligand, TRAIL, and Perforin/Granzyme B, Resulting in Reduced Plasma Viremia and Decreased HIV Reservoir Size during Acute HIV Infection in a Humanized Mouse Model
por: Chandrasekar, Aswath P., et al.
Publicado: (2022)

Modeling Kick-Kill Strategies toward HIV Cure
por: Hernandez-Vargas, Esteban A.
Publicado: (2017)

Reactivating latent HIV with PKC agonists induces resistance to apoptosis and is associated with phosphorylation and activation of BCL2
por: French, Andrea J., et al.
Publicado: (2020)

The long road to TRAIL therapy: a TRAILshort detour
por: Chandrasekar, Aswath P., et al.
Publicado: (2021)

Repurposing BCL-2 and Jak 1/2 inhibitors: Cure and treatment of HIV-1 and other viral infections
por: Reece, Monica D., et al.
Publicado: (2022)

Lnc(ing)RNAs to the “shock and kill” strategy for HIV-1 cure
por: Boliar, Saikat, et al.
Publicado: (2021)

“Much ado to achieve nothing: prospects for curing HIV infection”
por: Badley, Andrew D
Publicado: (2014)

Anti-apoptotic mechanisms of HIV: lessons and novel approaches to curing HIV
por: Cummins, Nathan W., et al.
Publicado: (2012)

Priming BCL-2 to kill: the combination therapy of tamoxifen and ABT-199 in ER(+) breast cancer
por: Deng, Jing, et al.
Publicado: (2013)

TRAIL Dependent Fratricidal Killing of gp120 Primed Hepatocytes by HCV Core Expressing Hepatocytes
por: Rizza, Stacey A., et al.
Publicado: (2011)

Kill or Cure
Publicado: (1859)

HIV Nef-mediated Ubiquitination of BCL2: Implications in Autophagy and Apoptosis
por: Castro-Gonzalez, Sergio, et al.
Publicado: (2021)

Animal Models for HIV Cure Research
por: Policicchio, Benjamin B., et al.
Publicado: (2016)

Landscape review of current HIV ‘kick and kill’ cure research - some kicking, not enough killing
por: Thorlund, Kristian, et al.
Publicado: (2017)

Crossroads of Cancer and HIV-1: Pathways to a Cure for HIV
por: Gavegnano, Christina, et al.
Publicado: (2019)

Eradication of HIV and Cure of AIDS, Now and How?
por: Zhang, Jielin, et al.
Publicado: (2013)

Targeting the Brain Reservoirs: Toward an HIV Cure
por: Marban, Céline, et al.
Publicado: (2016)

Inhibition of Bcl2L12 Attenuates Eosinophilia-Related Inflammation in the Heart
por: Chen, Xiao, et al.
Publicado: (2020)

Altering cell death pathways as an approach to cure HIV infection
por: Badley, A D, et al.
Publicado: (2013)

The B-Cell Follicle in HIV Infection: Barrier to a Cure
por: Bronnimann, Matthew P., et al.
Publicado: (2018)

Contribution of Sex Differences to HIV Immunology, Pathogenesis, and Cure Approaches
por: Moran, Jose A., et al.
Publicado: (2022)

Regulatory T Cells As Potential Targets for HIV Cure Research
por: Kleinman, Adam J., et al.
Publicado: (2018)

Advances in Developing CAR T-Cell Therapy for HIV Cure
por: Qi, Jinxin, et al.
Publicado: (2020)

Retraction: Inhibition of Bcl2L12 attenuates eosinophilia-related inflammation in heart
Publicado: (2023)

Infected Cell Killing by HIV-1 Protease Promotes NF-κB Dependent HIV-1 Replication
por: Bren, Gary D., et al.
Publicado: (2008)

Blocking Formation of the Stable HIV Reservoir: A New Perspective for HIV-1 Cure
por: Goonetilleke, Nilu, et al.
Publicado: (2019)

The Role of Immunomodulatory Receptors in the Pathogenesis of HIV Infection: A Therapeutic Opportunity for HIV Cure?
por: Chen, Hui, et al.
Publicado: (2020)

Patients with Discordant Responses to Antiretroviral Therapy Have Impaired Killing of HIV-Infected T Cells
por: Natesampillai, Sekar, et al.
Publicado: (2010)

To Kill But Not Be Killed: Controlling the Activity of Mammalian Pore-Forming Proteins
por: Krawczyk, Patrycja A., et al.
Publicado: (2020)

Editorial: Immune Surveillance of the HIV Reservoir: Mechanisms, Therapeutic Targeting and New Avenues for HIV Cure
por: Prado, Julia G., et al.
Publicado: (2020)

Antibody Conjugates for Targeted Therapy Against HIV-1 as an Emerging Tool for HIV-1 Cure
por: Umotoy, Jeffrey C., et al.
Publicado: (2021)

Mito-priming as a method to engineer Bcl-2 addiction
por: Lopez, Jonathan, et al.
Publicado: (2016)

Controlling HIV-1: Non-Coding RNA Gene Therapy Approaches to a Functional Cure
por: Ahlenstiel, Chantelle L., et al.
Publicado: (2015)

Editorial: Lymph Node T Cell Dynamics and Novel Strategies for HIV Cure
por: Petrovas, Constantinos, et al.
Publicado: (2018)

The Use of Toll-Like Receptor Agonists in HIV-1 Cure Strategies
por: Martinsen, Janne Tegder, et al.
Publicado: (2020)

Diverse Impacts of HIV Latency-Reversing Agents on CD8+ T-Cell Function: Implications for HIV Cure
por: Clutton, Genevieve Tyndale, et al.
Publicado: (2018)

Shock and kill within the CNS: A promising HIV eradication approach?
por: Nühn, Marieke M., et al.
Publicado: (2022)

Alternative Complement Pathway Inhibition Does Not Abrogate Meningococcal Killing by Serum of Vaccinated Individuals
por: Ispasanie, Emma, et al.
Publicado: (2021)

Challenges and Opportunities of Therapies Targeting Early Life Immunity for Pediatric HIV Cure
por: Berendam, Stella J., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_s3hs3ntuh2hqkn31lar6dbq4l2